CLINICAL_TRIALS
trial_result
· 2019-07-23
Clinical Trial Update: Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic Resistance [Phase 2, Phase 3]
Summary
A completed Phase 2/3 trial update on mineralocorticoid receptor antagonists for heart failure and loop diuretic resistance.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Columbia University | Conditions: Heart Failure | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-07-23